Replies to post #33478 on RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

That's my impression--actually it's very clear, if you look at the transcript of Biovail's CEO Bill Wells on their CC. This is not what they expected.

BUT--Even if the worst case scenario applies--single capsule formulation, pimavanserin-only arm--this is still doable. And I don't yet know if either of those is involved.

NeuroInvestment